Skip to main content
Clinical Trials/EUCTR2007-002968-10-AT
EUCTR2007-002968-10-AT
Active, not recruiting
Not Applicable

Treatment of Patients Suffering from Tumour Cachexia with Dronabinol (tetrahydrocannabinol) or PlaceboComparison of individually optimised dosages in a double blind, randomised parallel design - Dronabinol for tumour cachexia

Department of Medicine I, Clinical Dep. f. Oncology, University Hospital,0 sites74 target enrollmentOctober 30, 2007

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Department of Medicine I, Clinical Dep. f. Oncology, University Hospital,
Enrollment
74
Status
Active, not recruiting
Last Updated
14 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 30, 2007
End Date
TBD
Last Updated
14 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Department of Medicine I, Clinical Dep. f. Oncology, University Hospital,

Eligibility Criteria

Inclusion Criteria

  • Patients with tumour cachexia as patients with a loss of 3% or more of body weight during a period of up to 8 weeks preceding inclusion and fulfilling all in\- and exclusion criteria
  • Patients with the following diagnosis according to ICD\-10 are eligible: N. Bronchi, C 34\.9, no CNS metastases
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • life expectancy \< 2 months
  • subjects who are not available over a period of at least 8 weeks,
  • suspected ileus or other intestinal disorders including gastritis or bowel dysfunction
  • pancreatitis or pancreatic cancer
  • any known abuse of marijuana or a history of abuse of marijuana
  • serious concomitant medical illness/concomitant disease(s) which would preclude the patient from participating (e.g., serious psychiatric illness that would interfere with obtaining informed consent etc.),
  • participation in an experimental trial within the last 4 weeks
  • subjects where no written informed consent is received
  • female subjects of child bearing potential in which a pregnancy has not been ruled out by appropriate tests (fertile women must practice adequate contraception throughout the course of the study);

Outcomes

Primary Outcomes

Not specified

Similar Trials